PUBLISHER: Grand View Research | PRODUCT CODE: 1869624
PUBLISHER: Grand View Research | PRODUCT CODE: 1869624
The veterinary antimicrobial susceptibility testing market size was estimated at USD 1.13 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 8.06% from 2025 to 2033. The market is experiencing growth driven by rising regulatory & training initiatives among leading veterinary organizations, the growing potential of Artificial Intelligence (AI) in AST, growth in companion animal ownership and veterinary care, and growing Antimicrobial Resistance (AMR) among animals.
Veterinary professionals rely on Antimicrobial Susceptibility Testing (AST) to choose the most effective treatment for animal diseases. This testing identifies bacterial pathogens and determines antimicrobial agents that will deliver the best therapeutic outcomes, reducing the risk of antimicrobial resistance (AMR). For instance, in April 2025, Almaty hosted Kazakhstan's first FAO-led veterinary AST training, equipping specialists with international-standard skills to enhance AMR surveillance and strengthen national laboratory capacity, advancing One Health-driven animal and public health security. Such initiatives reinforce countries' laboratory capabilities, aligning veterinary practices with global One Health standards for sustainable health security.
Some of the leading veterinary organizations are driving improvements in AST by releasing standardized reference materials and practical resources. These initiatives empower veterinarians to make data-driven treatment decisions, enhance diagnostic accuracy, and promote responsible antimicrobial use, ultimately improving clinical outcomes and supporting sustainable animal health practices. For instance, in January 2024, the American Veterinary Medical Association (AVMA) strengthened its leadership in antimicrobial stewardship by publishing more than six comprehensive documents on animal antimicrobial susceptibility testing. These resources guide veterinary professionals in selecting the most effective antimicrobial therapies and predicting treatment outcomes for a wide range of bacterial infections.
The documents provide standardized guidelines for assessing pathogen sensitivity and resistance across multiple antimicrobial agents, enabling veterinarians to make rapid, evidence-based decisions for various animal species, including dogs, cats, cattle, poultry, and pigs. In addition, AVMA's antimicrobial stewardship program promotes responsible antimicrobial use, aiming to optimize treatment efficacy, improve patient outcomes, and reduce the spread of antimicrobial resistance and multidrug-resistant infections.
Global Veterinary Antimicrobial Susceptibility Testing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary antimicrobial susceptibility testing market report based on animal, product, end-use and region: